Virology
Journal
Overview
publication venue for
-
Parvovirus B19 integration into human CD36+ erythroid progenitor cells.
511:40-48.
2017
-
HTLV-1 Tax activates HIV-1 transcription in latency models.
504:45-51.
2017
-
Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies.
494:236-47.
2016
-
Limited variation during circulation of a polyomavirus in the human population involves the COCO-VA toggling site of Middle and Alternative T-antigen(s).
487:129-40.
2016
-
Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers.
486:116-120.
2015
-
Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease.
462-463:254-65.
2014
-
Neutralizing antibodies are unable to inhibit direct viral cell-to-cell spread of human cytomegalovirus.
444:140-7.
2013
-
The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.
444:292-300.
2013
-
Effects of sequence changes in the HIV-1 gp41 fusion peptide on CCR5 inhibitor resistance.
428:86-97.
2012
-
V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc.
427:158-65.
2012
-
Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors.
422:22-36.
2012
-
Resistance of a human immunodeficiency virus type 1 isolate to a small molecule CCR5 inhibitor can involve sequence changes in both gp120 and gp41.
413:47-59.
2011
-
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function.
401:236-47.
2010
-
Glycoprotein D actively induces rapid internalization of two nectin-1 isoforms during herpes simplex virus entry.
399:109-19.
2010
-
Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.
395:10-20.
2009
-
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.
389:108-21.
2009
-
Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities.
387:296-302.
2009
-
Biochemical and biophysical comparison of cleaved and uncleaved soluble, trimeric HIV-1 envelope glycoproteins.
385:275-81.
2009
-
Putative gene promoter sequences in the chlorella viruses.
380:388-93.
2008
-
Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
378:79-85.
2008
-
Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors.
377:401-407.
2008
-
The herpes simplex virus receptor nectin-1 is down-regulated after trans-interaction with glycoprotein D.
373:98-111.
2008
-
N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus.
372:187-200.
2008
-
Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody.
369:245-62.
2007
-
Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands.
364:281-90.
2007
-
Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
364:431-40.
2007
-
Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Δ32 heterozygote.
362:163-78.
2007
-
HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry.
361:212-28.
2007
-
A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120.
360:329-40.
2007
-
Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1.
360:199-208.
2007
-
Genetic analysis of poxvirus mRNA cap methyltransferase: Suppression of conditional mutations in the stimulatory D12 subunit by second-site mutations in the catalytic D1 subunit.
352:145-56.
2006
-
Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complex.
351:121-32.
2006
-
Interaction of small molecule inhibitors of HIV-1 entry with CCR5.
349:41-54.
2006
-
CD8 T cell effector maturation in HIV-1-infected children.
347:117-26.
2006
-
Use of alternate coreceptors on primary cells by two HIV-1 isolates.
339:136-44.
2005
-
Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
338:182-99.
2005
-
The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles.
338:154-72.
2005
-
Neutralization sensitivity of HIV-1 Env-pseudotyped virus clones is determined by co-operativity between mutations which modulate the CD4-binding site and those that affect gp120-gp41 stability.
337:136-48.
2005
-
Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
335:34-45.
2005
-
Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses.
328:19-29.
2004
-
Complete genomic DNA sequence of rock bream iridovirus.
325:351-63.
2004
-
The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4.
321:8-22.
2004
-
Bcl-2 and Bcl-xL overexpression inhibits cytochrome c release, activation of multiple caspases, and virus release following coxsackievirus B3 infection.
313:147-57.
2003
-
Amino acid substitutions within the heptad repeat domain 1 of murine coronavirus spike protein restrict viral antigen spread in the central nervous system.
312:369-80.
2003
-
Expression of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor monocistronic and bicistronic transcripts in primary effusion lymphomas.
287:62-70.
2001
-
A luciferase-reporter gene-expressing T-cell line facilitates neutralization and drug-sensitivity assays that use either R5 or X4 strains of human immunodeficiency virus type 1.
280:292-300.
2001
-
Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
279:459-70.
2001
-
Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.
272:347-56.
2000
-
Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects.
270:317-27.
2000
-
Passive infusion of immune serum into simian immunodeficiency virus- infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia.
270:237-249.
2000
-
Creation and repair of specific DNA double-strand breaks in vivo following infection with adenovirus vectors expressing Saccharomyces cerevisiae HO endonuclease.
266:211-24.
2000
-
Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
266:203-10.
2000
-
Adenovirus E4 34k and E4 11k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase.
263:307-12.
1999
-
Interactions among HIV gp120, CD4, and CXCR4: Dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies.
248:394-405.
1998
-
Altered pathogenesis of a mutant of the murine coronavirus MHV-A59 is associated with a Q159L amino acid substitution in the spike protein.
239:1-10.
1997
-
Syncytia formation induced by coronavirus infection is associated with fragmentation and rearrangement of the Golgi apparatus.
221:325-34.
1996
-
HIV-1 infection of cultured human adult oligodendrocytes.
217:211-9.
1996
-
Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression.
214:512-21.
1995
-
Intracerebral Hemorrhages and Infarction Induced by a Murine Leukemia Virus Is Influenced by Host Determinants within Endothelial Cells.
203:393-6.
1994
-
MHV-A59 fusion mutants are attenuated and display altered hepatotropism.
200:1-10.
1994
-
A model system for regulation of chronic HIV-1 infection in peripheral B lymphocytes.
196:433-41.
1993
-
An immune-selected point mutation in the transmembrane protein of n immunodeficiency virus type 1 (HXB2-Env:Ala 582(→ Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
196:332-7.
1993
-
A spleen necrosis virus-based retroviral vector which expresses two genes from a dicistronic mRNA.
186:669-75.
1992
-
CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro.
188:537-544.
1992
-
Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.
189:695-714.
1992
-
Early events in Epstein-Barr virus genome expression after activation: Regulation by second messengers of B cell activation.
185:922-8.
1991
-
Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in Vitro.
185:72-9.
1991
-
Reduction in CD4 binding affinity associated with removal of a single glycosylation site in the external glycoprotein of HIV-2.
180:853-6.
1991
-
Vaccinia virus induces cell fusion at acid ph and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein.
178:81-91.
1990
-
Activation of the major late promoter in adenovirus transformed cells by 5-azacytidine.
165:296-8.
1988
-
Homologous recombination between hepadnaviral genomes following in Vivo DNA transfection: Implications for studies of viral infectivity.
159:454-6.
1987
-
Effect of primary amines on interferon action.
117:510-5.
1982
-
Analysis of endogenous avian retrovirus DNA and RNA: Viral and cellular determinants of retrovirus gene expression.
114:8-22.
1981
-
Repair of lesions which cause premature termination of transcription in chicken embryo cells irradiated with ultraviolet light.
112:752-6.
1981
-
The genesis of rous sarcoma virus messenger RNAs.
112:714-28.
1981
-
Cell-free translation of purified avian sarcoma virus src mRNA.
110:476-8.
1981
-
Endogenous proviruses of random-bred chickens and ring-necked pheasants: Analysis with restriction endonucleases.
108:222-9.
1981
-
Integration of avian sarcoma virus DNA in chicken cells.
108:208-21.
1981
-
Organization of the endogenous proviruses of chickens: Implications for origin and expression.
108:189-207.
1981
-
Restriction endonuclease mapping of the DNA of Rous-Associated virus 0 reveals extensive homology in structure and sequence with avian sarcoma virus DNA.
108:177-88.
1981
-
Revertants of an ASV-transformed rat cell line have lost the complete provirus or sustained mutations insrc.
108:28-46.
1981
-
The structure and protein kinase activity of proteins encoded by nonconditional mutants and back mutants in thesrc gene of avian sarcoma virus.
108:47-70.
1981
-
Two cellular proteins that immunoprecipitate with the transforming protein of Rous sarcoma virus.
113:736-51.
1981
-
The vertebrate homology of the putative transforming gene of avian myelocytomatosis virus: Characteristics of the DNA locus and its RNA transcript.
105:415-24.
1980
-
Conformation of free and of integrated Moloney leukemia virus proviral DNA in preleukemic and leukemic BALB/Mo mice.
101:111-23.
1980
-
DNA of a chicken herpesvirus is associated with at least two chromosomes in a chicken lymphoblastoid cell line.
105:234-40.
1980
-
Identification and characterization of dimeric and trimeric circular forms of avian sarcoma virus-specific DNA.
103:425-33.
1980
-
Transformation-related proteins associated with Kirsten sarcoma virus.
106:335-48.
1980
-
Mutants of rous sarcoma virus with extensive deletions of the viral genome.
96:530-46.
1979
-
Endogenous mouse mammary tumor virus DNA is distributed among multiple mouse chromosomes.
92:46-55.
1979
-
Maturation of the head of bacteriophage T4: 9-aminoacridine blocks a late step in DNA packaging.
92:219-29.
1979
-
Characterization of a defective pseudotype particle of Kirsten sarcoma virus.
95:536-49.
1979
-
The replication of subgroup E avian retroviruses is blocked at or before viral DNA synthesis in restrictive chicken cells.
99:437-42.
1979
-
Characterization of dna complementary to nucleotide sequences adjacent to poly(A) at the 3′-terminus of the avian sarcoma virus genome.
79:183-97.
1977
-
Characterization of dna complementary to nucleotide sequences at the 5′-terminus of the avian sarcoma virus genome.
79:198-215.
1977
-
Biological and biochemical studies on the inactivation of avian oncoviruses by ultraviolet irradiation.
77:689-704.
1977
-
Characteristics of virus-specific RNA in avian sarcoma virus-transformed BHK-21 cells and revertants.
76:313-30.
1977
-
Detection and enumeration of transformation-defective strains of avian sarcoma virus with molecular hybridization.
76:675-84.
1977
-
Characterization of "early" temperature-sensitive mutants of avian sarcoma viruses: Biological properties, thermolability of reverse transcriptase in vitro, and synthesis of viral DNA in infected cells.
74:16-29.
1976
-
Differences between genomes of two strains of mouse mammary tumor virus as shown by partial RNA sequence analysis.
72:330-40.
1976
-
Nucleotide sequence homologies among mouse mammary tumor viruses.
70:550-3.
1976
-
Production of mouse mammary tumor virus by cultured cells in the absence and presence of hormones: Assay by molecular hybridization.
65:135-47.
1975
-
Characterization of the nucleic acid product of the visna virus RNA dependent DNA polymerase.
57:251-8.
1974
-
Homologies among the nucleotide sequences of the genomes of C-type viruses.
58:568-75.
1974
-
Serological analysis of reverse transcriptase of the Mason-Pfizer monkey virus.
59:335-8.
1974
-
The importance of DNA size for successful transfection of chicken embryo fibroblasts.
61:297-302.
1974
-
The persistence and expression of virus-specific DNA in revertants of Rous sarcoma virus-transformed BHK-21 cells.
62:512-21.
1974
-
RNA-directed DNA synthesis by virions of Rous sarcoma virus: Further characterization of the templates and the extent of their transcription.
52:264-74.
1973
-
Role of dna genes of Escherichia coli in M13 phage replication.
52:417-24.
1973
-
Inhibition of M13 phage synthesis by rifampicin in some rifampicin-resistant Escherichia coli mutants.
50:422-30.
1972
-
Corrigendum to "V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc" [Virology 427 (2012) 158-165].
428:76-83.
2012
-
Broadly neutralizing antibodies against HIV-1: Templates for a vaccine
2013
-
Is there enough gp120 in the body fluids of HIV-1-infected individuals to have biologically significant effects?
2004
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)